China BCT Pharmacy Group Inc
China BCT Pharmacy Group, Inc., through its subsidiaries, operates as an integrated pharmaceutical company in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Retail Pharmacy, and Manufacturing Pharmacy. The Pharmaceutical Distribution segment purchases pharmaceutical products from suppliers and distributes them to hospitals, retail drug stores, oth… Read more
China BCT Pharmacy Group Inc (CNBI) - Total Assets
Latest total assets as of June 2013: $299.39 Million USD
Based on the latest financial reports, China BCT Pharmacy Group Inc (CNBI) holds total assets worth $299.39 Million USD as of June 2013.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
China BCT Pharmacy Group Inc - Total Assets Trend (2007–2012)
This chart illustrates how China BCT Pharmacy Group Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
China BCT Pharmacy Group Inc - Asset Composition Analysis
Current Asset Composition (December 2012)
China BCT Pharmacy Group Inc's total assets of $299.39 Million consist of 81.5% current assets and 18.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.8% |
| Accounts Receivable | $154.28 Million | 63.0% |
| Inventory | $13.60 Million | 5.6% |
| Property, Plant & Equipment | $22.51 Million | 9.2% |
| Intangible Assets | $13.77 Million | 5.6% |
| Goodwill | $495.57K | 0.2% |
Asset Composition Trend (2007–2012)
This chart illustrates how China BCT Pharmacy Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: China BCT Pharmacy Group Inc's current assets represent 81.5% of total assets in 2012, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 8.8% of total assets in 2012, down from 100.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 63.0% of total assets.
China BCT Pharmacy Group Inc Competitors by Total Assets
Key competitors of China BCT Pharmacy Group Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
China BCT Pharmacy Group Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - China BCT Pharmacy Group Inc generates 0.99x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, China BCT Pharmacy Group Inc generates $8.59 in net profit.
China BCT Pharmacy Group Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.17 | 2.71 | 7.83 |
| Quick Ratio | 2.00 | 2.45 | 7.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $134.35 Million | $ 123.07 Million | $ 41.88K |
China BCT Pharmacy Group Inc - Advanced Valuation Insights
This section examines the relationship between China BCT Pharmacy Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.01 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 15.2% |
| Total Assets | $244.97 Million |
| Market Capitalization | $0.96 USD |
Valuation Analysis
Below Book Valuation: The market values China BCT Pharmacy Group Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: China BCT Pharmacy Group Inc's assets grew by 15.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for China BCT Pharmacy Group Inc (2007–2012)
The table below shows the annual total assets of China BCT Pharmacy Group Inc from 2007 to 2012.
| Year | Total Assets | Change |
|---|---|---|
| 2012-12-31 | $244.97 Million | +15.24% |
| 2011-12-31 | $212.58 Million | +50.19% |
| 2010-12-31 | $141.54 Million | +52.09% |
| 2009-12-31 | $93.06 Million | +316261.14% |
| 2008-12-31 | $29.42K | +41922.86% |
| 2007-12-31 | $70.00 | -- |